Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reiff

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Physical Chemistry. B|January 13, 2015
Radiation-Induced Chemical Changes to Iron OxidesSarah C Reiff, Jay A LaVerne
Der Anaesthesist|August 1, 1987
[Improving venous tolerance of methohexital]U Jost, E Wolter, C Reiff, et al.
Genes & Nutrition|November 27, 2008
NuGO contributions to GenePatternP J De Groot, C Reiff, C Mayer, et al.
ACS Applied Nano Materials|June 1, 2023
On-Site Detection of Neonicotinoid Pesticides Using Functionalized Gold Nanoparticles and Halogen BondingMolly M Sherard, Quang Minh Dang, Sophia C Reiff, et al.
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Physical Chemistry. B|January 13, 2015
Radiation-Induced Chemical Changes to Iron OxidesSarah C Reiff, Jay A LaVerne
Der Anaesthesist|August 1, 1987
[Improving venous tolerance of methohexital]U Jost, E Wolter, C Reiff, et al.
Genes & Nutrition|November 27, 2008
NuGO contributions to GenePatternP J De Groot, C Reiff, C Mayer, et al.
ACS Applied Nano Materials|June 1, 2023
On-Site Detection of Neonicotinoid Pesticides Using Functionalized Gold Nanoparticles and Halogen BondingMolly M Sherard, Quang Minh Dang, Sophia C Reiff, et al.
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Pageof 1